Cargando…

Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma

Little is known about the impact of adrenocortical carcinoma (ACC) on health-related quality of life (HRQoL), and no disease-specific questionnaire exists. This qualitative study aimed to identify relevant domains of HRQoL for patients with ACC. In 2 focus group interviews, we discussed concerns reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steenaard, Rebecca V, Kremers, Marjolein N T, Michon, Laura A, Zijlstra, Myrte, Haak, Harm R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174051/ https://www.ncbi.nlm.nih.gov/pubmed/32342024 http://dx.doi.org/10.1210/jendso/bvaa040

Ejemplares similares

Health-Related Quality of Life in Adrenocortical Carcinoma
por: Steenaard, Rebecca V., et al.
Publicado: (2019)

Health-Related Quality of Life in Adrenocortical Carcinoma: Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry
por: Steenaard, Rebecca V., et al.
Publicado: (2022)

Adrenocortical Carcinoma Treatment in the Netherlands: An Analysis From the Netherlands Cancer Registry From 2014 to 2019
por: Steenaard, Rebecca, et al.
Publicado: (2021)

Past, Present and Future of Epigenetics in Adrenocortical Carcinoma
por: Ettaieb, Madeleine, et al.
Publicado: (2020)

The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue
por: Steenaard, Rebecca V., et al.
Publicado: (2023)

Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma
por: Kimpel, Otilia, et al.
Publicado: (2022)

Patient’s perspective on improving the quality of acute medical care: determining patient reported outcomes
por: Kremers, Marjolein N T, et al.
Publicado: (2019)

EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity
por: Steenaard, Rebecca V., et al.
Publicado: (2022)

Negative illness perceptions are related to poorer health‐related quality of life among thyroid cancer survivors: Results from the PROFILES registry
por: Schoormans, Dounya, et al.
Publicado: (2020)

Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma.
por: Haak, H. R., et al.
Publicado: (1993)

Strengths and weaknesses of the acute care systems in the United Kingdom and the Netherlands: what can we learn from each other?
por: Kremers, Marjolein N. T., et al.
Publicado: (2019)

Mitotane in adrenocortical carcinoma.
por: Vassilopoulou-Sellin, R., et al.
Publicado: (1994)

Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)

What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
por: Basile, Vittoria, et al.
Publicado: (2021)

Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
por: Elhassan, Yasir, et al.
Publicado: (2021)

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
por: Siebert, Claudia, et al.
Publicado: (2019)

Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality
por: Ettaieb, Madeleine H. T., et al.
Publicado: (2020)

Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)

Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective
por: Gottberg, Kristina, et al.
Publicado: (2014)

Prospective cohort study of patients with advanced cancer and their relatives on the experienced quality of care and life (eQuiPe study): a study protocol
por: van Roij, Janneke, et al.
Publicado: (2020)

Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
por: Terzolo, Massimo, et al.
Publicado: (2021)

Quality of acute internal medicine: A patient-centered approach. Validation and usage of the Patient Reported Measure-acute care in the Netherlands
por: Kremers, Marjolein N. T., et al.
Publicado: (2020)

Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing
por: Yin, Anyue, et al.
Publicado: (2020)

Adrenocortical carcinoma: Report of two cases
por: Aparna, C., et al.
Publicado: (2011)

ODP025 Adrenocortical Carcinoma: A Rare but Life-Threatening Malignancy
por: Ortiz-Rivera, Monica, et al.
Publicado: (2022)

Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage
por: Russell, A J, et al.
Publicado: (1999)

Adrenocortical Carcinoma and Synchronous Malignancies
por: Guerrero, Marlon A., et al.
Publicado: (2010)

Apoptosis regulation in adrenocortical carcinoma
por: Pereira, Sofia S, et al.
Publicado: (2019)

Estrogen-secreting adrenocortical carcinoma
por: Jeong, You, et al.
Publicado: (2018)

Non-functioning adrenocortical carcinoma
por: Lenh, Bui-Van, et al.
Publicado: (2021)

Medical Approaches in Adrenocortical Carcinoma
por: Paragliola, Rosa Maria, et al.
Publicado: (2020)

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients.
por: Haak, H. R., et al.
Publicado: (1994)

The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
por: Mizdrak, Maja, et al.
Publicado: (2021)

Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022)

Laparoscopic Adrenalectomy for Large Adrenocortical Carcinoma
por: Machado, Norman Oneil, et al.
Publicado: (2015)

The challenge of developmental therapeutics for adrenocortical carcinoma
por: Costa, Ricardo, et al.
Publicado: (2016)

A case of metastatic adrenocortical carcinoma
por: Kuthiah, N, et al.
Publicado: (2019)

Extension of Adrenocortical Carcinoma into the Right Atrium
por: Castro-Dominguez, Yulanka, et al.
Publicado: (2017)

Prognostic Factors for Adrenocortical Carcinoma Outcomes
por: Scollo, Claudia, et al.
Publicado: (2016)

Adrenocortical carcinoma: an ominous cause of hirsutism
por: Radi, Suhaib, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vou7kkbikt9bhujmuoo570iph0